Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Win

20 Nov 2008 07:00

RNS Number : 5213I
e2v technologies PLC
20 November 2008
 



20 November  2008 

e2v technologies plc

Contract Win 

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces an £11m contract renewal to supply Varian Medical Systems, Inc., headquartered in Palo Alto, US, with electron devices for incorporation into linear accelerators, for use in radiotherapy cancer treatment and cargo screening systems.

The contract will be worth at least £11m (payments will be in US dollars at the prevailing exchange rate) over two years, and is the first of a number of anticipated multi-year contract renewals for electron devices used in linear accelerators. e2v's products generate and deliver the microwave power required from the linear accelerator to produce X-rays used in both the imaging and radiation treatment of tumours as well as the imaging systems within cargo screening equipment.

This contract represents an increase in business with this customer, has the potential to increase in value over the term of the agreement, and is in line with management's growth expectations for this sector.

Keith Attwood, Chief Executive of e2v said: ``This multi-year contract renewal with Varian is a demonstration of the strong and close relationships we build with our strategic partners.''

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7225

Jon Simmons/Sophie Kernon

   

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFKCKDABDDFDD
Date   Source Headline
22nd Sep 20112:09 pmRNSHolding(s) in Company
12th Sep 20115:02 pmRNSTotal Voting Rights
8th Aug 20113:52 pmRNSHolding(s) in Company
4th Aug 20117:00 amRNSVermiculite Processing System Field Trial
28th Jul 20117:00 amRNSNew Banking Facilities
27th Jul 20114:28 pmRNSResult of AGM
15th Jul 201110:17 amRNSHolding(s) in Company
8th Jul 201110:47 amRNSStatement Re Boiler Room Scams
8th Jun 20113:46 pmRNSTotal Voting Rights
6th Jun 20114:49 pmRNSFinal Dividend Timetable
6th Jun 20117:00 amRNSFinal Results
27th May 20119:45 amRNSHolding(s) in Company
21st Apr 20111:55 pmRNSTotal Voting Rights
21st Apr 201112:56 pmRNSDirector/PDMR Shareholding
12th Apr 20113:00 pmRNSe2v awarded up to £6.2m development grant
11th Apr 20117:00 amRNSYear end trading update & dividend declaration
4th Mar 201110:30 amRNSHolding(s) in Company
22nd Feb 20113:45 pmRNSHolding(s) in Company
2nd Feb 20112:00 pmRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSInterim Management Statement
28th Jan 20111:30 pmRNSDirectorate Change
20th Jan 20112:30 pmRNSBank arrangements concerning dividends
6th Dec 20104:57 pmRNSTotal Voting Rights
19th Nov 20103:21 pmRNSHolding(s) in Company
18th Nov 201012:12 pmRNSChange of Director's Details
17th Nov 20104:40 pmRNSHolding(s) in Company
15th Nov 20107:00 amRNSHalf Yearly Report
9th Nov 201012:11 pmRNSHolding(s) in Company
28th Oct 20107:00 amRNSAppointment of New Non Executive Director
12th Oct 201012:15 pmRNSHolding(s) in Company
11th Oct 20107:00 amRNSPeriod end update
7th Sep 20107:00 amRNSUpdate on Restructuring
25th Aug 201010:40 amRNSHolding(s) in Company
11th Aug 201011:15 amRNSHolding(s) in Company
4th Aug 20108:45 amRNSAwards under Long Term Incentive Plan
29th Jul 20102:57 pmRNSAGM Statement
26th Jul 20107:00 amRNSStrategy Briefing
23rd Jul 201012:42 pmRNSTotal Voting Rights
19th Jul 20107:00 amRNSInterim Management Statement
14th Jul 201010:15 amRNSHolding(s) in Company
21st Jun 20104:35 pmRNSPrice Monitoring Extension
4th Jun 201011:38 amRNSHolding(s) in Company
17th May 201012:53 pmRNSTotal Voting Rights
10th May 20107:00 amRNSAppointment of corporate broker
7th May 20102:00 pmRNSHolding(s) in Company
4th May 20101:35 pmRNSHolding(s) in Company
29th Apr 20109:19 amRNSAdditional Listing
28th Apr 20103:40 pmRNSHolding(s) in Company
12th Apr 20107:00 amRNS2010 Year End Trading update
7th Apr 20109:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.